Reports for NOVARTIS PHARMACEUTICALS CANADA INC
Company Name
NOVARTIS PHARMACEUTICALS CANADA INC
Totals |
||
Shortage reports |
161 |
|
| Actual shortage: | 10 (6%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 5 (3%) | |
| Resolved: | 146 (91%) | |
Discontinuation Reports |
52 |
|
| To be discontinued: | 1 (2%) | |
| Discontinued: | 51 (98%) | |
| Reversed: | 0 (0%) | |
Late reports |
34 (16%) |
|
Overdue reports |
5 (45%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| AFINITOR | 7.5MG | TABLET | Resolved | 2018-05-24 | 2018-07-10 | 50215 |
| ALOMIDE | 0.1% | SOLUTION | Resolved | 2018-06-01 | 2018-06-19 | 51063 |
| ALOMIDE | 0.1% | SOLUTION | Resolved | 2018-06-22 | 2018-07-27 | 52770 |
| ALOMIDE | 0.1% | SOLUTION | Resolved | 2018-08-15 | 2018-10-18 | 58228 |
| ALOMIDE | 0.1% | SOLUTION | Resolved | 2020-04-20 | 2020-09-08 | 112537 |
| ALOMIDE | 0.1% | SOLUTION | Resolved | 2022-09-29 | 2022-10-28 | 170488 |
| ALOMIDE | 0.1% | SOLUTION | Resolved | 2024-01-24 | 2024-04-11 | 217088 |
| ARZERRA | 100MG | SOLUTION | Resolved | 2017-03-23 | 2018-10-17 | 4096 |
| ARZERRA | 1000MG | SOLUTION | Resolved | 2017-03-23 | 2018-09-27 | 4093 |
| AZARGA | 0.5% 1.0% | SUSPENSION | Resolved | 2018-07-05 | 2018-07-27 | 54440 |
| AZARGA | 0.5% 1.0% | SUSPENSION | Resolved | 2020-02-04 | 2020-04-17 | 105259 |
| BETOPTIC S | .25% | SUSPENSION | Resolved | 2018-04-27 | 2018-06-06 | 47338 |
| BETOPTIC S | .25% | SUSPENSION | Resolved | 2018-11-23 | 2019-01-03 | 67490 |
| BETOPTIC S | .25% | SUSPENSION | Resolved | 2020-02-21 | 2020-04-21 | 106958 |
| BETOPTIC S | .25% | SUSPENSION | Resolved | 2020-03-31 | 2020-04-21 | 110235 |
| BETOPTIC S | 0.25% | SUSPENSION | Resolved | 2020-04-27 | 2020-05-21 | 113330 |
| BETOPTIC S | 0.25% | SUSPENSION | Resolved | 2020-05-21 | 2020-08-28 | 115462 |
| CILOXAN | 0.3% | SOLUTION | Resolved | 2018-09-28 | 2018-10-17 | 62545 |
| CILOXAN | 0.3% | SOLUTION | Resolved | 2022-09-14 | 2022-10-07 | 169228 |
| CILOXAN | 0.3% | OINTMENT | Resolved | 2019-02-11 | 2019-04-29 | 75343 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| AFINITOR | 7.5MG | TABLET | Discontinued | 2018-07-09 | 2018-07-10 | 54891 |
| ARZERRA | 100MG | SOLUTION | Discontinued | 2019-03-11 | 2019-03-12 | 78215 |
| ARZERRA | 1000MG | SOLUTION | Discontinued | 2019-03-11 | 2019-03-12 | 78219 |
| BETOPTIC S | 0.25% | SUSPENSION | Discontinued | 2022-09-28 | 2023-01-19 | 170389 |
| EXTAVIA | 0.3MG | POWDER FOR SOLUTION | Discontinued | 2022-01-12 | 2022-02-11 | 152532 |
| FLAREX | 0.1% | SUSPENSION | To be discontinued | 2024-08-27 | 2024-08-27 | 235987 |
| FORADIL DRY POWDER CAPSULES FOR INHALATION | 12MCG | CAPSULE | Discontinued | 2022-10-18 | 2023-01-25 | 172087 |
| HYCAMTIN | 4MG | POWDER FOR SOLUTION | Discontinued | 2017-04-26 | 2019-06-11 | 8129 |
| ILARIS | 150MG | POWDER FOR SOLUTION | Discontinued | 2019-09-11 | 2019-09-12 | 93588 |
| ISOPTO CARPINE | 4% | LIQUID | Discontinued | 2022-05-11 | 2022-07-14 | 160361 |
| LESCOL XL | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2020-03-20 | 2020-04-17 | 109153 |
| LIORESAL D.S. TAB 20MG | 20MG | TABLET | Discontinued | 2020-01-10 | 2020-02-24 | 103075 |
| LIORESAL INTRATHECAL 0.05MG/ML | 0.05MG | SOLUTION | Discontinued | 2023-08-10 | 2023-09-19 | 201576 |
| LIORESAL INTRATHECAL 0.5MG/ML | 0.5MG | SOLUTION | Discontinued | 2023-08-17 | 2023-09-19 | 202298 |
| LIORESAL INTRATHECAL 2MG/ML | 2MG | SOLUTION | Discontinued | 2023-08-10 | 2023-09-19 | 201573 |
| LIORESAL TAB 10MG | 10MG | TABLET | Discontinued | 2020-01-10 | 2020-07-10 | 103078 |
| LOPRESOR 100MG | 100MG | TABLET | Discontinued | 2018-01-09 | 2018-01-09 | 35454 |
| LOPRESOR 50MG | 50MG | TABLET | Discontinued | 2018-01-09 | 2019-03-20 | 35419 |
| LOPRESOR 50MG | 50MG | TABLET | Discontinued | 2018-01-09 | 2018-01-09 | 35425 |
| LOPRESOR 50MG | 50MG | TABLET | Discontinued | 2019-04-05 | 2019-04-05 | 80614 |